Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Liminal BioSciences Inc. PFSCF


Primary Symbol: LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Bullboard Posts
Comment by stockbuphoonon Jul 07, 2019 10:07pm
90 Views
Post# 29894083

RE:RE:RE:RE:RE:i say next 2 weeks we have 1 NR

RE:RE:RE:RE:RE:i say next 2 weeks we have 1 NRPando, seriously, name all the milestones they hit in the last 3 years spending $350M. I’ll start. Alstrom Phase 2 open label for 10 patients, a couple of preclinical trials, no progress on placebo trials, major delays on every
aspect of Ryplazim BLA, no progress on wound healing, no progress on TMP, shutdown of IVIG, no other proteins moved forward, no other 4050 or 4547  trials. Conspiracy theories? You must be joking. Penicillin (or wonder drug 4050) in 2015 with early efficacy in 5 organs has been stalled for years. Check out 2015/16 presentations. Best and Clulow were there in 2015. Pritchard was there. These guys are either complete imbeciles or complete crooks. And Pritchard deserves $1-3B comparable with his salary, right? Oh wait, Thomson extended the loan to 2024 even when Best said at 2 recent meetings that they had no chance of getting equity into company when there was $120M Loan in place. Lawyers and judges will reasonably believe that something is amiss when listening to the audio tapes of Jan 25, Apr 2 and June AGM.  This is fun pointing out the obvious. 

pandorom999 wrote: we are above 1.5 cents arent we? for the rest, if i believed in your conspiracy  theories, i wouldnt be wasting my time and energy here:) But u like it here, dont you? Its cool.. i dont judge u, enjoy.


Bullboard Posts